BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 9154782)

  • 1. Transvaginal sonographic and hysteroscopic findings in postmenopausal women receiving tamoxifen.
    Marconi D; Exacoustos C; Cangi B; Perroni A; Zupi E; Valli E; Romanini C
    J Am Assoc Gynecol Laparosc; 1997 May; 4(3):331-9. PubMed ID: 9154782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transvaginal Sonographic and Hysteroscopic Findings in Postmenopausal Women Receiving Tamoxifen.
    Marconi D; Exacoustos C; Cangi B; Perroni A; Zupi E; Valli E; Romanini C
    J Am Assoc Gynecol Laparosc; 1996 Aug; 3(4, Supplement):S28. PubMed ID: 9074172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endometrial evaluation in postmenopausal breast cancer patients receiving tamoxifen: an ultrasound, color flow Doppler, hysteroscopic and histological study.
    Exacoustos C; Zupi E; Cangi B; Chiaretti M; Arduini D; Romanini C
    Ultrasound Obstet Gynecol; 1995 Dec; 6(6):435-42. PubMed ID: 8903921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sonographic, hysteroscopic, and histologic evaluation of the endometrium in postmenopausal women with breast cancer receiving tamoxifen.
    Ceci O; Bettocchi S; Marello F; Nappi L; Chiechi LM; Laricchia L; Masciandaro A
    J Am Assoc Gynecol Laparosc; 2000 Feb; 7(1):77-81. PubMed ID: 10648743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anastrozole versus tamoxifen treatment in postmenopausal women with endocrine-responsive breast cancer and tamoxifen-induced endometrial pathology.
    Gerber B; Krause A; Reimer T; Mylonas I; Makovitzky J; Kundt G; Janni W
    Clin Cancer Res; 2006 Feb; 12(4):1245-50. PubMed ID: 16489080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes mimicking endometrial neoplasia in postmenopausal, tamoxifen-treated women with breast cancer: a transvaginal Doppler study.
    Achiron R; Lipitz S; Sivan E; Goldenberg M; Horovitz A; Frenkel Y; Mashiach S
    Ultrasound Obstet Gynecol; 1995 Aug; 6(2):116-20. PubMed ID: 8535913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tamoxifen use and endometrial lesions: hysteroscopic, histological, and immunohistochemical findings in postmenopausal women with breast cancer.
    Dibi RP; Zettler CG; Pessini SA; Ayub AV; de Almeida SB; da Silveira GP
    Menopause; 2009; 16(2):293-300. PubMed ID: 19034048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endometrial evaluation with transvaginal US and hysterosonography in asymptomatic postmenopausal women with breast cancer receiving tamoxifen.
    Fong K; Kung R; Lytwyn A; Trudeau M; Chapman W; Nugent P; Glanc P; Manchul L; Szabunio D; Myhr T
    Radiology; 2001 Sep; 220(3):765-73. PubMed ID: 11526280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The endometrium in asymptomatic breast cancer patients on tamoxifen: value of transvaginal ultrasonography with saline infusion and Doppler flow.
    Develioğlu OH; Omak M; Bilgin T; Esmer A; Tüfekçi M
    Gynecol Oncol; 2004 May; 93(2):328-35. PubMed ID: 15099941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of ultrasonography, hysteroscopy, and biopsy in the diagnosis of endometrial lesions in postmenopausal tamoxifen-treated patients.
    Giorda G; Crivellari D; Veronesi A; Perin T; Campagnutta E; Carbone A; Scarabelli C
    Acta Obstet Gynecol Scand; 2002 Oct; 81(10):975-80. PubMed ID: 12366490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hysteroscopically targeted biopsies compared with blind samplings in endometrial assessment of menopausal women taking tamoxifen for breast cancer.
    Garuti G; Cellani F; Colonnelli M; Garzia D; Gonfiantini C; Luerti M
    J Am Assoc Gynecol Laparosc; 2004 Feb; 11(1):62-7. PubMed ID: 15104834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discrepancy between ultrasonography and hysteroscopy and histology of endometrium in postmenopausal breast cancer patients using tamoxifen.
    Mourits MJ; Van der Zee AG; Willemse PH; Ten Hoor KA; Hollema H; De Vries EG
    Gynecol Oncol; 1999 Apr; 73(1):21-6. PubMed ID: 10094875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective longitudinal study of ultrasound screening for endometrial abnormalities in women with breast cancer receiving tamoxifen.
    Fung MF; Reid A; Faught W; Le T; Chenier C; Verma S; Brydon E; Fung KF
    Gynecol Oncol; 2003 Oct; 91(1):154-9. PubMed ID: 14529676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transvaginal endometrial sonography in postmenopausal women taking tamoxifen.
    Tesoro MR; Borgida AF; MacLaurin NA; Asuncion CM
    Obstet Gynecol; 1999 Mar; 93(3):363-6. PubMed ID: 10074980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of adjuvant tamoxifen on the endometrium in postmenopausal women with breast cancer: a prospective long-term study using transvaginal ultrasound.
    Gerber B; Krause A; Müller H; Reimer T; Külz T; Makovitzky J; Kundt G; Friese K
    J Clin Oncol; 2000 Oct; 18(20):3464-70. PubMed ID: 11032586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pretreatment and prospective assessment of endometrium in menopausal women taking tamoxifen for breast cancer.
    Garuti G; Grossi F; Centinaio G; Sita G; Nalli G; Luerti M
    Eur J Obstet Gynecol Reprod Biol; 2007 May; 132(1):101-6. PubMed ID: 16678960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of transvaginal ultrasonographic and diagnostic hysteroscopic findings in postmenopausal breast cancer patients treated with tamoxifen.
    Gao WL; Zhang LP; Feng LM
    Chin Med J (Engl); 2011 Aug; 124(15):2335-9. PubMed ID: 21933565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hysteroscopic assessment of menopausal breast-cancer patients taking tamoxifen; there is a bias from the mode of endometrial sampling in estimating endometrial morbidity?
    Garuti G; Grossi F; Cellani F; Centinaio G; Colonnelli M; Luerti M
    Breast Cancer Res Treat; 2002 Apr; 72(3):245-53. PubMed ID: 12058966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endometrial thickness in tamoxifen-treated patients: correlation with clinical and pathologic findings.
    Hann LE; Giess CS; Bach AM; Tao Y; Baum HJ; Barakat RR
    AJR Am J Roentgenol; 1997 Mar; 168(3):657-61. PubMed ID: 9057510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uterine pathologies in patients undergoing tamoxifen therapy for breast cancer: ultrasonographic, hysteroscopic and histological findings.
    Le Donne M; Lentini M; De Meo L; Benedetto V; Mesiti M
    Eur J Gynaecol Oncol; 2005; 26(6):623-6. PubMed ID: 16398223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.